ZA935718B - Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them - Google Patents

Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them

Info

Publication number
ZA935718B
ZA935718B ZA935718A ZA935718A ZA935718B ZA 935718 B ZA935718 B ZA 935718B ZA 935718 A ZA935718 A ZA 935718A ZA 935718 A ZA935718 A ZA 935718A ZA 935718 B ZA935718 B ZA 935718B
Authority
ZA
South Africa
Prior art keywords
seco
nucleosides
liponucleotides
pharmaceutical compositions
antiviral action
Prior art date
Application number
ZA935718A
Other languages
English (en)
Inventor
Harald Zilch
Dieter Hermmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA935718B publication Critical patent/ZA935718B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA935718A 1992-08-08 1993-08-06 Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them ZA935718B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226279A DE4226279A1 (de) 1992-08-08 1992-08-08 Liponucleotide von Seco-Nucleosiden, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel

Publications (1)

Publication Number Publication Date
ZA935718B true ZA935718B (en) 1995-02-06

Family

ID=6465143

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935718A ZA935718B (en) 1992-08-08 1993-08-06 Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them

Country Status (20)

Country Link
EP (1) EP0654036B1 (da)
JP (1) JP3479299B2 (da)
KR (1) KR100243440B1 (da)
CN (1) CN1040984C (da)
AT (1) ATE152114T1 (da)
AU (1) AU672994B2 (da)
CA (1) CA2141030A1 (da)
DE (2) DE4226279A1 (da)
DK (1) DK0654036T3 (da)
ES (1) ES2104163T3 (da)
FI (1) FI109699B (da)
GR (1) GR3023960T3 (da)
HU (1) HUT72605A (da)
IL (1) IL106588A (da)
MX (1) MX9304676A (da)
NO (1) NO304986B1 (da)
NZ (1) NZ254813A (da)
TW (1) TW306924B (da)
WO (1) WO1994003465A1 (da)
ZA (1) ZA935718B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
DE4402492A1 (de) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern
US7517858B1 (en) * 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
KR100389558B1 (ko) * 2000-10-11 2003-06-27 주식회사 한스환경엔지니어링 유리섬유 강화플라스틱 성형품의 표면처리용 직물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel

Also Published As

Publication number Publication date
DK0654036T3 (da) 1997-11-03
EP0654036B1 (de) 1997-04-23
KR100243440B1 (ko) 2000-03-02
MX9304676A (es) 1994-03-31
EP0654036A1 (de) 1995-05-24
FI109699B (fi) 2002-09-30
NZ254813A (en) 1996-05-28
JPH08500345A (ja) 1996-01-16
ES2104163T3 (es) 1997-10-01
WO1994003465A1 (de) 1994-02-17
TW306924B (da) 1997-06-01
DE4226279A1 (de) 1994-02-10
CA2141030A1 (en) 1994-02-09
GR3023960T3 (en) 1997-09-30
NO950445L (no) 1995-02-07
IL106588A (en) 1998-01-04
DE59306286D1 (de) 1997-05-28
CN1085908A (zh) 1994-04-27
CN1040984C (zh) 1998-12-02
HU9500374D0 (en) 1995-03-28
AU4708293A (en) 1994-03-03
ATE152114T1 (de) 1997-05-15
AU672994B2 (en) 1996-10-24
IL106588A0 (en) 1993-12-08
NO304986B1 (no) 1999-03-15
FI950533A0 (fi) 1995-02-07
JP3479299B2 (ja) 2003-12-15
NO950445D0 (no) 1995-02-07
FI950533A (fi) 1995-02-07
KR950702998A (ko) 1995-08-23
HUT72605A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
MX9202851A (es) Derivados de fosfato de los glucosidos de 4-desmetilepipodofilotoxina y composicion farmaceutica que los contiene.
IL105727A (en) 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
AU1779488A (en) Polysaccharides and antiviral drugs containing the same as active ingredient
NZ244462A (en) Fused benzazepine derivatives and medicaments
FI945363A (fi) Uusia merkaptoasetyyliamidopyridatso (1,2)pyridatsiini-, pyratsolo(1,2)pyridatsiini-, pyridatso (1,2-a)(1,2)diatsepiini- ja pyratsolo(1,2-a)(1,2)diatsepiinijohdannaisia, jotka ovat käyttökelpoisia enkefalisaasin ja ACE:n estäjinä
CA2133177A1 (en) Rapamycin formulations for oral administration
IL88765A0 (en) Adenosine derivatives and pharmaceutical compositions containing them
ES2033426T3 (es) Procedimiento para la preparacion de composiciones farmaceuticas de liberacion controlada que contienen 3'-azido-3'-desoxitimidina.
CA2085354A1 (en) Ether lipid-nucleoside covalent conjugates
NZ222716A (en) A lipid composition comprising 97% by weight or greater of phosphatidylcholine
ZA935718B (en) Liponucleotides of seco-nucleosides and pharmaceutical compositions with antiviral action containing them
ES8207184A1 (es) Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
MY119473A (en) Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
SV1996000001A (es) Nuevas aplicaciones de dimero de lisozima
MX9203613A (es) Derivados de adenosina y composiciones farmaceuticas que los contienen.
ES8607217A1 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
JPS6416890A (en) Antioxidant
ES2032209T3 (es) Derivados de proteinas que contienen hierro en forma altamente biodisponible, su preparacion y composiciones farmaceuticas que los contienen.
EP0210703A3 (en) Acylphosphorotriamides useful as lipid-altering agents
ES2039284T3 (es) Un procedimiento para preparar derivados de la 1-benzoil-2-oxo-5-alcoxi-pirrolidina.
IT8720225A0 (it) Composizioni cosmetiche contenenti come principio attivo adenosin monofosfato ciclico e fosfatidil inositolo o inositolo